News

April 19, 2021April 19, 2021

Assessing Treatment Burden, Complexity May Improve Therapy Adherence

News

Routine evaluations of how cystic fibrosis (CF) patients and their families are coping with the burden of therapeutic regimens — usually daily therapies that are complex and time-consuming — are ... Read more

April 16, 2021April 16, 2021

Bioengineer to Use $2M Grant to Study Gene Editing for CF

News

A bioengineer at Rice University will use a more than $2 million federal grant for a project to “repair” harmful mutations that cause cystic fibrosis (CF) using a potentially more ... Read more

April 15, 2021April 15, 2021

Claire’s Place Foundation Launches Website to Connect CF Community

cystic fibrosis, News

To mark its 10th anniversary, Claire’s Place Foundation has launched a website that seeks to connect the community of people affected by cystic fibrosis (CF). “Our new website is a ... Read more

April 14, 2021April 14, 2021

‘Fun’ Sweat-measuring Sticker May Aid CF Diagnosis in Children

News

A soft skin sticker that can rapidly measure chloride levels in sweat, which are elevated in cystic fibrosis (CF) patients, may help avoid delays in diagnosis and treatment associated with ... Read more

April 13, 2021April 13, 2021

CF Therapy’s Effectiveness With Rare Mutations Can Be Determined in Lab

cystic fibrosis, News

An ex vivo technique using nasal epithelial cells from a young girl carrying a rare mutation profile for cystic fibrosis (CF) was successful at predicting the efficacy of an approved ... Read more

April 12, 2021April 12, 2021

Respinova’s Pulsehaler Device Wins FDA OK

News

Respinova’s non-invasive Pulsehaler, a medical device meant to ease breathing in patients with airway restrictions, such as in cystic fibrosis (CF), has been cleared for marketing in the U.S. Pulsehaler ... Read more

April 9, 2021April 9, 2021

Phase 2 Trial of BX004, Phage Therapy for Bacterial Infections, Advancing

News

A Phase 2 clinical trial assessing the safety and efficacy of BX004 — BiomX’s phage therapy candidate for Pseudomonas aeruginosa infections in people with cystic fibrosis (CF) — remains on track to have ... Read more

April 8, 2021April 8, 2021

Trial Testing Personalized Chest Physiotherapy System for Mucus Clearance

cystic fibrosis, News

A clinical trial underway in Israel is investigating how well a personalized chest physiotherapy system compares with traditional airway clearance techniques in people with cystic fibrosis (CF) and other chronic lung ... Read more

April 7, 2021April 7, 2021

OPTION 2 Trial Testing MS1819 for EPI Posts ‘Mixed’ Topline Results

News

Treatment with MS1819 for exocrine pancreatic insufficiency (EPI) — when the pancreas does not release enough digestive enzymes and the body doesn’t receive proper nutrition — was found to be ... Read more

April 6, 2021April 6, 2021

Olgram Raises $1.77M to Develop New Class of Antibiotics Against Resistant Bacteria

cystic fibrosis, News

Olgram has raised €1.5 million (about $1.77 million) in seed funding from investors to speed its development of antibiotics to clear persistent bacteria responsible for chronic, repeat infections. The company’s ... Read more